BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 11371498)

  • 1. Advanced glycation: an important pathological event in diabetic and age related ocular disease.
    Stitt AW
    Br J Ophthalmol; 2001 Jun; 85(6):746-53. PubMed ID: 11371498
    [No Abstract]   [Full Text] [Related]  

  • 2. Aging and Vision.
    Alavi MV
    Adv Exp Med Biol; 2016; 854():393-9. PubMed ID: 26427437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seeing into the future. Vision and aging.
    Kalina RE
    West J Med; 1997 Oct; 167(4):253-7. PubMed ID: 9348756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular disease and driving.
    Wood JM; Black AA
    Clin Exp Optom; 2016 Sep; 99(5):395-401. PubMed ID: 27156178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Getting the focus back. There's new hope for people with age-related macular degeneration.
    Baldauf S
    US News World Rep; 2007 Mar; 142(8):65-6. PubMed ID: 17348339
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular Inflammation Risk Factors in Retinal Disease.
    Soto I; Krebs MP; Reagan AM; Howell GR
    Annu Rev Vis Sci; 2019 Sep; 5():99-122. PubMed ID: 31226014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of age-related ocular conditions.
    Akpek EK; Smith RA
    Am J Manag Care; 2013 May; 19(5 Suppl):S67-75. PubMed ID: 23725498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Eger Macular Stressometer: pilot study.
    Schmitt NJ; Grover DA; Feldon SE
    Am J Ophthalmol; 2003 Aug; 136(2):314-7. PubMed ID: 12888055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products (AGEs) and diabetic vascular complications.
    Yamagishi S; Nakamura K; Imaizumi T
    Curr Diabetes Rev; 2005 Feb; 1(1):93-106. PubMed ID: 18220586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease.
    Williams ME
    Curr Diab Rep; 2004 Dec; 4(6):441-6. PubMed ID: 15539009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic targeting of advanced glycation end-products in age-related diseases.
    Rowan S; Bejarano E; Taylor A
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3631-3643. PubMed ID: 30279139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of advanced glycation end-products (AGE) in late diabetic complications.
    Sensi M; Pricci F; Pugliese G; De Rossi MG; Petrucci AF; Cristina A; Morano S; Pozzessere G; Valle E; Andreani D
    Diabetes Res Clin Pract; 1995 Apr; 28(1):9-17. PubMed ID: 7587917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity and reliability study for the NEI-VFO-39 scale in chronic ophthalmic diseases--Turkish version.
    Iyigun E; Bayer A; Tastan S; Demiralp M; Acikel C
    Acta Ophthalmol; 2010 Jun; 88(4):e115-9. PubMed ID: 20346083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Burden of Vision Impairment and Eye Diseases in Persons with Chronic Kidney Disease - A Population-Based Study.
    Wong CW; Lamoureux EL; Cheng CY; Cheung GC; Tai ES; Wong TY; Sabanayagam C
    EBioMedicine; 2016 Mar; 5():193-7. PubMed ID: 27077127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aminoguanidine and other AGE inhibitors].
    Kawakami M; Kuroki M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():601-5. PubMed ID: 12387057
    [No Abstract]   [Full Text] [Related]  

  • 16. The Evolving Functions of Autophagy in Ocular Health: A Double-edged Sword.
    Chai P; Ni H; Zhang H; Fan X
    Int J Biol Sci; 2016; 12(11):1332-1340. PubMed ID: 27877085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine.
    Li YM; Steffes M; Donnelly T; Liu C; Fuh H; Basgen J; Bucala R; Vlassara H
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3902-7. PubMed ID: 8632987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual complications in diabetes mellitus: beyond retinopathy.
    Khan A; Petropoulos IN; Ponirakis G; Malik RA
    Diabet Med; 2017 Apr; 34(4):478-484. PubMed ID: 27917530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Diabetes Federation meeting, 1997: nephropathy, retinopathy, and glycation.
    Bloomgarden ZT
    Diabetes Care; 1998 Sep; 21(9):1560-6. PubMed ID: 9727909
    [No Abstract]   [Full Text] [Related]  

  • 20. Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes.
    Cartledge JJ; Eardley I; Morrison JF
    BJU Int; 2001 Mar; 87(4):402-7. PubMed ID: 11251537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.